FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016558303> ?p ?o ?g. }

• W2016558303 endingPage "647" @default.
• W2016558303 startingPage "639" @default.
• W2016558303 abstract "As a part of our efforts to use small organic matrix metalloproteinase (MMP) inhibitors with improved characteristics for the diagnosis and treatment of different kinds of tumor tissues, biphenylsulfonamide analogues were synthesized. This study reports on the in vivo biodistribution of iodine-123-labeled biphenylsulfonide and analogues in A549 lung carcinoma inoculated into athymic mice and the evaluation of their suitability as imaging agents using a single photon emission computed tomography (SPECT) camera.The radioiodinated carboxylic and hydroxamic MMP inhibitors 2-(4'- [(123)I]iodobiphenyl-4-sulfonylamino)-3-(1H-indol-3-yl)-propionic acid (1') and 2-(4'-[(123)I]iodobiphenyl-4- sulfonylamino)-3-(1H-indol-3-yl)-propionamide (2') were synthesized by electrophilic aromatic substitution of the tributylstannyl derivatives. Planar gamma camera imaging was performed in nu/nu athymic mice bearing an A549 tumor using a Toshiba GCA-9300A/hg SPECT camera in planar mode equipped with a high-resolution, parallel-hole collimator.Radiosynthesis of (1') and (2') resulted in radiochemical yields of 60 +/- 5% (n +/- 3) and 70 +/- 5% (n = 6), respectively. Evaluation of tumors induced in athymic mice by the inoculation of non-small cell lung A549 carcinoma cells, showed a tumor uptake of 0.27-0.01 percent injected dose per gram (%ID/g) (3 hours-48 hours p.i.), a tumor-blood ratio of 0.7, a tumor-muscle ratio of 1.6, and a tumor-fat ratio of 0.5 at 24 hours (p.i.) for compound 1'. For compound 2' a tumor uptake of 0.7-0.04 %ID/g (3 hours-48 hours p.i.), a postinjection tumor-blood ratio of 1.2, a tumor-muscle ratio of 3.2, and a tumor-fat ratio of 2.4 at 48 hours p.i. was observed. SPECT evaluation confirmed the results obtained from biodistribution.In vivo evaluation of these radioiodinated carboxylic and hydroxamic MMP inhibitor tracers revealed that they do not appear suitable as tumor-imaging agents." @default.
• W2016558303 created "2016-06-24" @default.
• W2016558303 creator A5002342405 @default.
• W2016558303 creator A5037543427 @default.
• W2016558303 creator A5046901291 @default.
• W2016558303 creator A5050390108 @default.
• W2016558303 creator A5051462107 @default.
• W2016558303 creator A5059449850 @default.
• W2016558303 creator A5067342192 @default.
• W2016558303 creator A5084744120 @default.
• W2016558303 date "2005-12-01" @default.
• W2016558303 modified "2023-10-06" @default.
• W2016558303 title "Tryptophane-Based Biphenylsulfonamide Matrix Metalloproteinase Inhibitors as Tumor Imaging Agents" @default.
• W2016558303 cites W1968817120 @default.
• W2016558303 cites W1985462222 @default.
• W2016558303 cites W1990858735 @default.
• W2016558303 cites W1995249913 @default.
• W2016558303 cites W2003500892 @default.
• W2016558303 cites W2009904294 @default.
• W2016558303 cites W2025563024 @default.
• W2016558303 cites W2033341544 @default.
• W2016558303 cites W2041838448 @default.
• W2016558303 cites W2050039508 @default.
• W2016558303 cites W2052650371 @default.
• W2016558303 cites W2055758035 @default.
• W2016558303 cites W2057504721 @default.
• W2016558303 cites W2057896496 @default.
• W2016558303 cites W2059910197 @default.
• W2016558303 cites W2060688195 @default.
• W2016558303 cites W2061846703 @default.
• W2016558303 cites W207753262 @default.
• W2016558303 cites W2094607729 @default.
• W2016558303 cites W2111091733 @default.
• W2016558303 cites W2124132332 @default.
• W2016558303 cites W2129394604 @default.
• W2016558303 cites W4214827383 @default.
• W2016558303 doi "https://doi.org/10.1089/cbr.2005.20.639" @default.
• W2016558303 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16398616" @default.
• W2016558303 hasPublicationYear "2005" @default.
• W2016558303 type Work @default.
• W2016558303 sameAs 2016558303 @default.
• W2016558303 citedByCount "16" @default.
• W2016558303 countsByYear W20165583032012 @default.
• W2016558303 countsByYear W20165583032013 @default.
• W2016558303 countsByYear W20165583032014 @default.
• W2016558303 countsByYear W20165583032016 @default.
• W2016558303 countsByYear W20165583032019 @default.
• W2016558303 countsByYear W20165583032020 @default.
• W2016558303 crossrefType "journal-article" @default.
• W2016558303 hasAuthorship W2016558303A5002342405 @default.
• W2016558303 hasAuthorship W2016558303A5037543427 @default.
• W2016558303 hasAuthorship W2016558303A5046901291 @default.
• W2016558303 hasAuthorship W2016558303A5050390108 @default.
• W2016558303 hasAuthorship W2016558303A5051462107 @default.
• W2016558303 hasAuthorship W2016558303A5059449850 @default.
• W2016558303 hasAuthorship W2016558303A5067342192 @default.
• W2016558303 hasAuthorship W2016558303A5084744120 @default.
• W2016558303 hasConcept C109523444 @default.
• W2016558303 hasConcept C142724271 @default.
• W2016558303 hasConcept C150903083 @default.
• W2016558303 hasConcept C185592680 @default.
• W2016558303 hasConcept C202751555 @default.
• W2016558303 hasConcept C207001950 @default.
• W2016558303 hasConcept C2775842073 @default.
• W2016558303 hasConcept C2775958869 @default.
• W2016558303 hasConcept C2776256026 @default.
• W2016558303 hasConcept C2776970183 @default.
• W2016558303 hasConcept C2777807558 @default.
• W2016558303 hasConcept C2778172261 @default.
• W2016558303 hasConcept C29331040 @default.
• W2016558303 hasConcept C2984398910 @default.
• W2016558303 hasConcept C2989005 @default.
• W2016558303 hasConcept C502942594 @default.
• W2016558303 hasConcept C55493867 @default.
• W2016558303 hasConcept C71924100 @default.
• W2016558303 hasConcept C81729549 @default.
• W2016558303 hasConcept C86803240 @default.
• W2016558303 hasConceptScore W2016558303C109523444 @default.
• W2016558303 hasConceptScore W2016558303C142724271 @default.
• W2016558303 hasConceptScore W2016558303C150903083 @default.
• W2016558303 hasConceptScore W2016558303C185592680 @default.
• W2016558303 hasConceptScore W2016558303C202751555 @default.
• W2016558303 hasConceptScore W2016558303C207001950 @default.
• W2016558303 hasConceptScore W2016558303C2775842073 @default.
• W2016558303 hasConceptScore W2016558303C2775958869 @default.
• W2016558303 hasConceptScore W2016558303C2776256026 @default.
• W2016558303 hasConceptScore W2016558303C2776970183 @default.
• W2016558303 hasConceptScore W2016558303C2777807558 @default.
• W2016558303 hasConceptScore W2016558303C2778172261 @default.
• W2016558303 hasConceptScore W2016558303C29331040 @default.
• W2016558303 hasConceptScore W2016558303C2984398910 @default.
• W2016558303 hasConceptScore W2016558303C2989005 @default.
• W2016558303 hasConceptScore W2016558303C502942594 @default.
• W2016558303 hasConceptScore W2016558303C55493867 @default.
• W2016558303 hasConceptScore W2016558303C71924100 @default.
• W2016558303 hasConceptScore W2016558303C81729549 @default.
• W2016558303 hasConceptScore W2016558303C86803240 @default.
• W2016558303 hasIssue "6" @default.

• next